Humphrey Rachel (CIK 0001579781)

Latest company ownership

Role: Chief Medical Officer
Shares held
90,000
Last filed at
Jan 29, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 2, 2018 Mar 5, 2018 CytomX Therapeutics, Inc. Chief Medical Officer Sell 7.5 -16,160 -34.83% $484.8K
Feb 28, 2018 Mar 2, 2018 CytomX Therapeutics, Inc. Chief Medical Officer Sell 7.5 -23,840 -44.09% $715.2K